Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$8.37 -2.56%
Market Cap
$26.6M
Price Target
Refer to Report
Volume
30.9K
52wk Range
$5.1239 - $20.8
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.